Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Omega Healthcare Investors Inc. Common Stock (OHI) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Omega Healthcare Investors Inc. Common StockTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Omega Healthcare Investors Inc. Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Omega Healthcare Investors Inc. Common Stock trades at $45 (market cap $13.70B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Omega Healthcare Investors Inc. Common Stock is the larger of the two by market cap, and Omega Healthcare Investors Inc. Common Stock pays a 6.02% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Omega Healthcare Investors Inc. Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

OHIPCVX
Market Cap
$13.70B$10.51B
Volume
1,169,9532,644,694
Sector
Real EstateHealth
52-Week High
$51.72$73.82
52-Week Low
$39.53$40.32
Typical Hold Time
0 Days0 Days
Enterprise Value
$17.69B$9.14B
Dividend Yield
6.02%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OHI
100% Buy0% Sell
Avg holding period · 0 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About Omega Healthcare Investors Inc. Common Stock

Omega Healthcare Investors Inc. is a real estate investment trust that owns skilled nursing and assisted living facilities, which it leases to healthcare operators under long-term, primarily triple-net lease structures. It partners with healthcare providers across US and UK markets.

Read more on OHI →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →